BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Intrexon Corporation 

201 Industrial Road, Suite 420
San Carlos, California 94070

201 Gateway Boulevard, 1st Floor
South San Francisco  California  94080  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Founded in 1998, Intrexon Corporation is a privately held biotechnology company focused on the industrial engineering of synthetic biology. Intrexon is deploying its extensive capabilities to rapidly design and produce novel and enhanced biological products and processes across multiple industry sectors, including: human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science. The company’s advanced bioindustrial engineering platform enables Better DNA™ technology by combining breakthroughs in DNA control systems with corresponding advancements in modular transgene design, assembly, and optimization to enable unprecedented control over the function and output of living cells.

Our mission is to redefine the biotechnology development process by engineering complex multigenic biological and cellular systems at unprecedented scale, dramatically reducing the time, cost, and risks associated with synthetic biology. With an extensive and expanding patent portfolio, Intrexon is working with key channel partners throughout our commercial divisions to utilize the industrial engineering of synthetic biology in developing new products and processes, which will alleviate shortages of essential nutrients, bring better medicines to more people, and generate renewable fuels and other resources. Our Better DNA™ technology provides the foundation to industrialize the development of high-performing biological products and enable many new possibilities across broad industries.

Intrexon’s commercial and core technology divisions are located within the country’s major biotechnology hotbeds. In California, San Francisco is the primary site of the Protein Production and Industrial Products Divisions, with our Cell Engineering Unit nearby in San Diego. Intrexon’s expansive Germantown, Maryland facility is centrally located within the Mid-Atlantic biotech region and is currently home to our Human Therapeutics and Animal Science Divisions, as well as our Molecular Engineering Unit. Corporate headquarters, as well as the UltraVector Technology Division are both located in Blacksburg, Virginia. Finally, the southern states host a second site for our Protein Production Division in Charleston, South Carolina, in addition to our Agricultural Biotech Division in Research Triangle Park, North Carolina.

We are always seeking those who share our passion for excellence, hard work, creativity, and moving beyond the limitations of traditional biotech. ?With Intrexon you will have an exceptional opportunity to join the forefront of the bioindustrial revolution and contribute directly to the future of synthetic biology applications and products.

Please visit www.DNA.com for further information on our company.


 Key Statistics


Email:
Ownership:

Web Site: Intrexon Corporation
Employees:
Symbol: 
 



Industry
Biotechnology






 Company News
Intrexon Corporation Announces First Quarter Financial Results 5/8/2014 6:49:32 AM
Synthetic Biologics, Inc. (SYN)' Reports Preclinical Data To Support Clinical Development Of Novel Pertussis Therapeutic 4/23/2014 9:01:34 AM
Codexis, Inc. (CDXS) Sells Its Hungarian Operations To Intrexon Corporation 3/14/2014 9:17:27 AM
Intrexon Corporation To Present At The 2014 Barclays Global Healthcare Conference 3/11/2014 7:18:22 AM
Intrexon Corporation Completes Acquisition Of MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) 3/7/2014 9:48:59 AM
Fibrocell Science, Inc. And Intrexon Corporation Expand Collaboration To Include Hypermobility-Type Ehlers-Danlos Syndrome 1/13/2014 11:51:05 AM
Intrexon Corporation Announces A Research And Development Collaboration With Johnson & Johnson (JNJ) Innovation to Advance New Skin And Hair Products 12/30/2013 9:35:03 AM
Intrexon Corporation Announces Second Quarter Financial Results 9/20/2013 6:32:44 AM
Intrexon Corporation Prices Initial Public Offering 8/8/2013 6:54:54 AM
AmpliPhi Biosciences (TGEN) Establishes Collaboration With Intrexon Corporation 4/16/2013 9:34:08 AM
12